New brain-machine interface technology allows those who are immobile to control their wheelchairs through mind control. The BMI allows users to traverse natural and cluttered environments after training.
Patterns of cognitive impairments suffered by those infected with COVID-19 were similar to those of healthy people who are sleep deprived. Additionally, worse symptoms of cognitive impairment in coronavirus patients were directly correlated with more severe infection.
Proteins associated with motor neuron disease, or ALS are present in the gut many years before disease pathologies can be found in the brain. A stool sample or gut biopsy could help identify the presence of MND-associated proteins years before symptoms appear.
In rats, high-sugar diets lower the ability of the taste system to sense sweetness. However, curbing high sugar in the diet allowed sensitivity to sweetness to return.
Researchers discovered personal odors can alter in people with Parkinson's disease. Based on this, they identified specific markers for Parkinson's in sebum, an oily substance secreted from the skin. They developed a new, non-invasive swab test that can identify Parkinson's with 95% accuracy.
Researchers are developing a monthly monoclonal antibody therapy for the treatment and management of chronic pain. The hope is this new therapy can replace opioids for pain management.
Not only did microbes diversify within early modern human hosts as they traveled and settled in different geographical locations, they also followed human evolution by limiting themselves to the gut.
Axolotls have the ability to regenerate brain areas following an injury. Researchers have mapped cell types and genes associated with neurodegeneration in the axolotl brain, discovering some similarities in the human brain. The findings could pave the way for new neurodegenerative therapies.